Denis M. Schewe

3.4k citations

54 papers · 1.6k indexed · h-index 18

Impact in

Oncology top 5%
- Cancer Cells and Metastasis
Hematology top 5%
- Acute Myeloid Leukemia Research

Papers in

Hematology 17
- Acute Myeloid Leukemia Research 11
- Chronic Myeloid Leukemia Treatments 6
Public Health, Environmental and Occupational Health 27
- Acute Lymphoblastic Leukemia research 25

Co-authors: Julio A. Aguirre‐Ghiso Paloma Bragado Sarah Krause Hernán G. Fariña Falguni Parikh Yeriel Estrada Carla S. Capobianco Ameera Alsadeq
Journals: Blood (11 papers)Cancer Research (5 papers)Frontiers in Immunology (3 papers)Blood Advances (3 papers)HemaSphere (3 papers)
Partner nations: Germany United States Netherlands

In The Last Decade

Denis M. Schewe

53 papers receiving 1.6k citations

Peers

Countries citing papers authored by Denis M. Schewe

Since Specialization

Citations

This map shows the geographic impact of Denis M. Schewe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Denis M. Schewe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Denis M. Schewe more than expected).

Fields of papers citing papers by Denis M. Schewe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Denis M. Schewe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Denis M. Schewe. The network helps show where Denis M. Schewe may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Denis M. Schewe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Denis M. Schewe Line = papers co-authored together Denis M. Schewe links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A quiescence-like/TGF-β1-specific CRISPRi screen reveals drug uptake transporters as secondary targets of kinase inhibitors in AML Drug Resistance Updates ·Julia Biener, Walaa AlMubarak, Sofia Traikov, Michael Schroeder, L. Bowman, J. Linek, J. C. J. Cardenas, (unknown), Alexander Krüger, Peter Mirtschink, Gustavo Baretton, Evelin Schröck, Denis M. Schewe, Claudia R. Ball, Martin Bornhäuser, Hanno Glimm, Marius Bill, Alexander Arthur Wurm	2025	0
2	Enhanced potency of immunotherapy against B‐cell precursor acute lymphoblastic leukemia by combination of an Fc‐engineered CD19 antibody and CD47 blockade HemaSphere ·Denis M. Schewe, Fotini Vogiatzi, Robert A. Mautino, Dariusz Karłowicz, Y. James Kang, Christian Wichmann, Caeley M Reever, Cara Glynn, Hao-Yu Ge, Dimitrios Mougiakakos, Heiko Bruns, Lennart Lenk, Thomas Valerius, Andreas Humpe, Matthias Peipp, Christian Kellner	2024	1
3	Refractory and relapsed paediatric ACC in the MET studies – A challenging situation necessitating novel diagnostic and therapeutic concepts SHILAP Revista de lepidopterología ·Michaela Kuhlen, Marina Kunstreich, Ha NTT, Stefan A. Wudy, Paul‐Martin Holterhus, Christian Vokuhl, Л. В. Мітіогло, R. W. Girdler, Guido Seitz, Christoph Slavetinsky, Jörg Fuchs, Denis M. Schewe, Rainer Claus, Pascal D. Johann, Michael C. Frühwald, Peter Vorwerk, Antje Redlich	2023	2
4	Abstract 2957: CD127 is expressed by acute lymphoblastic leukemias and is efficiently targeted by the IL7R-antagonist OSE-127 through macrophage-mediated antibody dependent phagocytosis Cancer Research ·Irène Baccelli, Lennart Lenk, Larissa A. B. Gilhespy, Un Lam Choi, Т. Б. Мялтон, 信行森島, Seyedeh Nazanin Hajjri, Hassam Ahmad, Beat Bornhäuser, Jean‐Pierre Bourquin, Fotini Vogiatzi, Simon Raffel, Martin Schrappe, Gunnar Cario, Monika Brüggemann, Denis M. Schewe, Nicolas Poirier	2023	1
5	Accumulation of T-cell-suppressive PD-L1^high extracellular vesicles is associated with GvHD and might impact GvL efficacy Journal for ImmunoTherapy of Cancer ·Elena Brumă, Franziska Karl, Romy Loschinski, Andrej Stoll, Simon Völkl, Andreas Gießl, Soeb Aripin, Heiko Bruns, Ursula Schlötzer‐Schrehardt, Martin Böttcher, Denis M. Schewe, Thomas Fischer, Regina Jitschin, Andréas Mackensen, Dimitrios Mougiakakos	2023	10
6	Perspectives of targeting LILRB1 in innate and adaptive immune checkpoint therapy of cancer Frontiers in Immunology ·Dariusz Karłowicz, Robert A. Mautino, Y. James Kang, Cristhian Ruiz Cardozo, Denis M. Schewe, Andreas Humpe, Christian Kellner	2023	24
7	Myeloid checkpoint blockade improves killing of T-acute lymphoblastic leukemia cells by an IgA2 variant of daratumumab Frontiers in Immunology ·Zi-Qi Liew, Christian Arndt, Е.И. Якушенко, Scott Summers, Thies Rösner, Katja Klausz, Christian Kellner, Santosh Kumar Nayan, Lorenz Bastian, Fotini Vogiatzi, Jeanette H.W. Leusen, Renate Burger, Denis M. Schewe, Matthias Peipp, Thomas Valerius	2022	11
8	Dual Fc optimization to increase the cytotoxic activity of a CD19-targeting antibody Frontiers in Immunology ·姜挺, 木棚照一, Jacob Appelbaum, Un Lam Choi, Steffen Krohn, Nishika V. Deole, Elisa Cappuzzello, Anja Lux, Falk Nimmerjahn, Ralf J. Ludwig, Scott Summers, Thies Rösner, Thomas Valerius, Denis M. Schewe, Christian Kellner, Katja Klausz, Matthias Peipp	2022	6
9	Engineering of CD19 Antibodies: A CD19-TRAIL Fusion Construct Specifically Induces Apoptosis in B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) Cells In Vivo Journal of Clinical Medicine ·Un Lam Choi, Lennart Lenk, Das, Fotini Vogiatzi, 姜挺, Fabian‐Simon Frielitz, Katja Klausz, Thies Rösner, Thomas Valerius, Anna Trauzold, Matthias Peipp, Christian Kellner, Denis M. Schewe	2021	5
10	Preclinical Evidence for the Efficacy of CD79b Immunotherapy in B Cell Precursor Acute Lymphoblastic Leukemia Blood ·Lennart Lenk, Un Lam Choi, Fotini Vogiatzi, Larissa A. B. Gilhespy, 輝明佐藤, 千晴甲田, Christian Vokuhl, Julia Richter, Michela Carlet, Irmela Jeremias, Thomas Valerius, Martin Schrappe, Gunnar Cario, Hassan Jumaa, Elias Hobeika, Monika Brüggemann, Ameera Alsadeq, Denis M. Schewe	2021	2
11	Repurposing anthelmintic agents to eradicate resistant leukemia Blood Cancer Journal ·Caterina Mezzatesta, Clara Ying Yi Lim, Anna Guinot, Cornelia Eckert, Denis M. Schewe, Markéta Žaliová, Luciana Vinti, Blerim Marovca, Jimena Marín, Silvia Jenni, Júlia Aguadé-Gorgorió, Arend von Stackelberg, Martin Schrappe, Franco Locatelli, Martin Stanulla, Gunnar Cario, Jean‐Pierre Bourquin, Beat Bornhäuser	2020	4
12	Involvement of the central nervous system in acute lymphoblastic leukemia: opinions on molecular mechanisms and clinical implications based on recent data Cancer and Metastasis Reviews ·Lennart Lenk, Ameera Alsadeq, Denis M. Schewe	2020	57
13	An Anti-EGFR IgA That Displays Improved Pharmacokinetics and Myeloid Effector Cell Engagement In Vivo Cancer Research ·Stefan Lohse, Saskia Meyer, Laura A.P.M. Meulenbroek, J.H. Marco Jansen, Maaike Nederend, J.H. Westing, Katja Klausz, Uwe Möginger, Stefanie Derer, Thies Rösner, Christian Kellner, Denis M. Schewe, Peter Sondermann, Sanjay Tiwari, Daniel Kolarich, Matthias Peipp, Jeanette H.W. Leusen, Thomas Valerius	2015	62
14	Effects of p38α/β inhibition on acute lymphoblastic leukemia proliferation and survival in vivo Leukemia ·Ameera Alsadeq, Ryan Kondracki, Sarah Krause, Michela Carlet, Irmela Jeremias, Christian Vokuhl, Sonja Loges, Julio A. Aguirre‐Ghiso, Anna Trauzold, Gunnar Cario, Martin Stanulla, Martin Schrappe, Denis M. Schewe	2015	7
15	Identification of markers that functionally define a quiescent multiple myeloma cell sub-population surviving bortezomib treatment BMC Cancer ·Mahir Mahmudov, Verónica Calvo, Noa Biran, Keren Osman, Ajai Chari, James C. Paton, Adrienne W. Paton, Kateri Moore, Denis M. Schewe, Julio A. Aguirre‐Ghiso	2015	21
16	TGF-β2 dictates disseminated tumour cell fate in target organs through TGF-β-RIII and p38α/β signalling Nature Cell Biology ·Paloma Bragado, Yeriel Estrada, Falguni Parikh, Sarah Krause, Carla S. Capobianco, Hernán G. Fariña, Denis M. Schewe, Julio A. Aguirre‐Ghiso	2013	360
17	Inhibition of eIF2α Dephosphorylation Maximizes Bortezomib Efficiency and Eliminates Quiescent Multiple Myeloma Cells Surviving Proteasome Inhibitor Therapy Cancer Research ·Denis M. Schewe, Julio A. Aguirre‐Ghiso	2009	122
18	Computational Identification of a p38SAPK-Regulated Transcription Factor Network Required for Tumor Cell Quiescence Cancer Research ·Alejandro P. Adam, Ajish George, Denis M. Schewe, Paloma Bragado, Bibiana V. Iglesias, Aparna C. Ranganathan, Antonis Kourtidis, Douglas S. Conklin, Julio A. Aguirre‐Ghiso	2009	129
19	ATF6α-Rheb-mTOR signaling promotes survival of dormant tumor cells in vivo Proceedings of the National Academy of Sciences ·Denis M. Schewe, Julio A. Aguirre‐Ghiso	2008	281
20	Analysis of Specific Transcriptional Regulators as Early Predictors of Independent Prognostic Relevance in Resected Colorectal Cancer Clinical Cancer Research ·Gabriele D. Maurer, Jöerg H. Leupold, Denis M. Schewe, Vaithiyanathan Senthilvel, Ronald Kates, H Hornung, Ulla Lau‐Werner, S. Post, Heike Allgayer	2007	45

About Denis M. Schewe

Denis M. Schewe is a scholar working on Hematology, Public Health, Environmental and Occupational Health, Oncology, Immunology and Genetics, having authored 54 papers that have together received 1.6k indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (25 papers), CAR-T cell therapy research (13 papers), Acute Myeloid Leukemia Research (11 papers), Monoclonal and Polyclonal Antibodies Research (8 papers), Childhood Cancer Survivors' Quality of Life (7 papers), Immune Cell Function and Interaction (7 papers), Chronic Myeloid Leukemia Treatments (6 papers) and Neuroblastoma Research and Treatments (5 papers). The work is most often cited by research in Oncology (632 citations), Hematology (242 citations), Cancer Research (316 citations), Cell Biology (329 citations) and Immunology (308 citations). Denis M. Schewe has collaborated with scholars based in Germany, United States and Netherlands. Frequent co-authors include Julio A. Aguirre‐Ghiso, Paloma Bragado, Sarah Krause, Hernán G. Fariña, Falguni Parikh, Yeriel Estrada, Carla S. Capobianco, Ameera Alsadeq, Lennart Lenk and Martin Schrappe. Their work appears in journals such as Blood, Cancer Research, Frontiers in Immunology, Blood Advances and HemaSphere.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact